Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Iwai North America ALyS505NK-AC1000: Xeno-free (Serum free) cell culture mediums with IL-2 (1000IU/mL) for activation of Human NK cells. Size: 200mL

Supplier:  Iwai North America 01610P02

Encompass_Preferred

ALyS505NK-AC1000 is xeno-free cell culture medium with IL-2(1000IU/mL), optimized for human natural killer (NK) cells derived from peripheral blood mononuclear cells (PBMCs). ALySNK-AC demonstrates a remarkable capability to increased collection of NK cells, coupled with heightened cytotoxicity. Unlike the majority of NK-cell culture kits, ALyS NKs unique medium composition establishes optimal conditions for NK cells, leading to a significant increase in NK cell percentage, typically ranging from 60% to 80%.By employing ALyS505NK-AC for activation and ALyS505NK-EX for expansion, one can attain a highly pure, NK-rich population of cells in 14 days without the need for sorting with beads or flow cytometry.1. Mikawa, S., Matsuda, A., Kamemori, Y., Asanuma, S. & Kitagawa, H. Enhancement of natural killer cell activity by oral administration of a fermented soybean product in dogs. Open Veterinary Journal 11, 394–400 (2021) doi: 10.5455/OVJ.2021.v11.i3.10.

Catalog No. NC2733024


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.